Hybio Pharmaceutical Co Ltd SZSE:300199:
SAYS CO PLANS TO RAISE UP TO 968 MILLION YUAN ($135.90 million) VIA SHARE PRIVATE PLACEMENT TO FUND PROJECTS, REPLENISH CAPITAL
($1 = 7.1231 Chinese yuan renminbi)
Hybio Pharmaceutical Plans To Raise Fund Via Share Private Placement
Hybio Pharmaceutical Co., Ltd. on 6ix
Later from Hybio Pharmaceutical
- Hybio's generic weight-loss drug set for FDA review
- Hybio Pharmaceutical's Liraglutide Injection Approved By China's National Medical Products Administration
- Hybio Pharmaceutical Unit's Chemical API Liraglutide Approved By China's Regulator
Follow Hybio Pharmaceutical into a list and get an email when it puts out news.
Follow Hybio Pharmaceutical